Comparative Pharmacology
Head-to-head clinical analysis: CHLORAPREP ONE STEP versus CIDA STAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLORAPREP ONE STEP versus CIDA STAT.
CHLORAPREP ONE-STEP vs CIDA-STAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate disrupts microbial cell membrane integrity and precipitates cytoplasmic contents, providing rapid bactericidal activity against a broad spectrum of gram-positive and gram-negative bacteria, as well as some fungi and viruses. Isopropyl alcohol denatures proteins and disrupts cell membranes, enhancing antimicrobial activity.
CIDA-STAT is a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor that competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to increased hepatic LDL receptor expression and reduced plasma LDL cholesterol levels.
Apply chlorhexidine 2% and isopropyl alcohol 70% solution to the surgical site as a single preoperative skin preparation; no additional scrubbing or rubbing required.
10 mg orally once daily
None Documented
None Documented
Chlorhexidine has a terminal elimination half-life of approximately 1-2 hours in plasma after intravenous administration in animal studies; however, after topical application, systemic levels are undetectable, making half-life clinically irrelevant.
Terminal half-life: 12-15 hours; requires dose adjustment in renal impairment (CrCl <30 mL/min)
Chlorhexidine is primarily excreted unchanged in feces (>90%) after oral administration, with minimal renal excretion (<1%). After cutaneous application, negligible systemic absorption occurs, and any absorbed chlorhexidine is excreted renally as unchanged drug (<1% of dose).
Renal: 30% unchanged; Biliary/fecal: 60% as metabolites; 10% other
Category C
Category C
Antiseptic
Antiseptic